Search

Your search keyword '"Ko, Young-Guk"' showing total 45 results

Search Constraints

Start Over You searched for: Author "Ko, Young-Guk" Remove constraint Author: "Ko, Young-Guk" Topic angioplasty, balloon, coronary Remove constraint Topic: angioplasty, balloon, coronary
45 results on '"Ko, Young-Guk"'

Search Results

1. Safety and usefulness of a novel short track sliding balloon catheter.

2. Neointima characteristics as a prognostic marker for drug-coated balloon angioplasty in patients with in-stent restenosis: an optical coherence tomography study.

3. Comparison of clinical outcomes of two different types of paclitaxel-coated balloons for treatment of patients with coronary in-stent restenosis.

4. Different Neointimal Pattern in Early vs. Late In-Stent Restenosis and Clinical Outcomes After Drug-Coated Balloon Angioplasty - An Optical Coherence Tomography Study.

5. Comparison between drug-coated balloon angioplasty and second-generation drug-eluting stent placement for the treatment of in-stent restenosis after drug-eluting stent implantation.

6. Serial randomized comparison of strut coverage of everolimus- and first-generation sirolimus-eluting stents.

7. Temporal course of neointimal hyperplasia following drug-eluting stent implantation: a serial follow-up optical coherence tomography analysis.

8. Relationship between endothelial vasomotor function and strut coverage after implantation of drug-eluting stent assessed by optical coherence tomography.

9. A new strategy for discontinuation of dual antiplatelet therapy: the RESET Trial (REal Safety and Efficacy of 3-month dual antiplatelet Therapy following Endeavor zotarolimus-eluting stent implantation).

10. Major determinants for the uncovered stent struts on optical coherence tomography after drug-eluting stent implantation.

11. Optical coherence tomography findings of very late stent thrombosis after drug-eluting stent implantation.

12. Favorable neointimal coverage in everolimus-eluting stent at 9 months after stent implantation: comparison with sirolimus-eluting stent using optical coherence tomography.

13. Efficacy of drug-eluting stents for treating in-stent restenosis of drug-eluting stents (from the Korean DES ISR multicenter registry study [KISS]).

14. Efficacy of clotinab in acute myocardial infarction trial-ST elevation myocardial infarction (ECLAT-STEMI).

15. Impact of contrast-induced acute kidney injury with transient or persistent renal dysfunction on long-term outcomes of patients with acute myocardial infarction undergoing percutaneous coronary intervention.

16. A newly formed and ruptured atheromatous plaque within neointima after drug-eluting stent implantation: 2-year follow-up intravascular ultrasound and optical coherence tomography studies.

17. Relation of homocysteinemia to contrast-induced nephropathy in patients undergoing percutaneous coronary intervention.

18. Evaluation of neointimal morphology of lesions with or without in-stent restenosis: an optical coherence tomography study.

19. A new stent design with multiple radio-opaque markers for protection of side-branch vessels in bifurcation lesions: HJ stents.

20. A randomized study assessing the effects of pretreatment with cilostazol on periprocedural myonecrosis after percutaneous coronary intervention.

21. Long-term (≥2 years) follow-up optical coherence tomographic study after sirolimus- and paclitaxel-eluting stent implantation: comparison to 9-month follow-up results.

22. Comparison of 2 point-of-care platelet function tests, VerifyNow Assay and Multiple Electrode Platelet Aggregometry, for predicting early clinical outcomes in patients undergoing percutaneous coronary intervention.

23. Angiographic and intravascular ultrasound follow up of paclitaxel- and sirolimus-eluting stent after poststent high-pressure balloon dilation: from the poststent optimal stent expansion trial.

24. Quantification of regional calcium burden in chronic total occlusion by 64-slice multi-detector computed tomography and procedural outcomes of percutaneous coronary intervention.

25. Efficacy of fractional flow reserve measurements at side branch vessels treated with the crush stenting technique in true coronary bifurcation lesions.

26. Neointimal coverage on drug-eluting stent struts crossing side-branch vessels using optical coherence tomography.

27. Different vascular healing patterns with various drug-eluting stents in primary percutaneous coronary intervention for ST-segment elevation myocardial infarction: optical coherence tomographic findings.

28. Efficacy of high-dose atorvastatin loading before primary percutaneous coronary intervention in ST-segment elevation myocardial infarction: the STATIN STEMI trial.

29. Comparison of neointimal coverage of sirolimus-eluting stents and paclitaxel-eluting stents using optical coherence tomography at 9 months after implantation.

30. A new stent design for the treatment of true bifurcation lesions: H-side branch stents.

31. Comparison of the effect of preinterventional arterial remodeling on intimal hyperplasia after implantation of a sirolimus- or paclitaxel-eluting stent.

32. Evaluation in 3 months duration of neointimal coverage after zotarolimus-eluting stent implantation by optical coherence tomography: the ENDEAVOR OCT trial.

33. Impact of coronary artery collaterals on infarct size assessed by serial cardiac magnetic resonance imaging after primary percutaneous coronary intervention in patients with acute myocardial infarction.

34. Significant association of coronary stent fracture with in-stent restenosis in sirolimus-eluting stents.

35. Comparison of sirolimus-eluting stent and paclitaxel-eluting stent for long-term cardiac adverse events in diabetic patients: the Korean Multicenter Angioplasty Team (KOMATE) Registry.

36. Correlation of serial cardiac magnetic resonance imaging parameters with early resolution of ST-segment elevation after primary percutaneous coronary intervention.

37. Intravascular ultrasound evaluation of optimal drug-eluting stent expansion after poststent balloon dilation using a noncompliant balloon versus a semicompliant balloon (from the Poststent Optimal Stent Expansion Trial [POET]).

38. A multicenter, randomized, open-label, therapeutic, and exploratory trial to evaluate the tolerability and efficacy of platelet glycoprotein IIb/IIIa receptor blocker (Clotinab) in high-risk patients with percutaneous coronary intervention.

39. Association of RAGE gene polymorphisms with in-stent restenosis in non-diabetic Korean population.

40. Inflammatory and vasoactive factors in the aspirate from the culprit coronary artery of patients with acute myocardial infarction.

41. Coronary artery intervention after cytostatics treatment in unstable angina patient with essential thrombocythemia. A case report and literature review.

42. Intracoronary aspiration for bailout management of the no-reflow during percutaneous coronary intervention.

43. Does a carbon ion-implanted surface reduce the restenosis rate of coronary stents?

44. Intracoronary 166Holmium brachytherapy combined with cutting balloon angioplasty for the treatment of in-stent restenosis.

Catalog

Books, media, physical & digital resources